Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
StageZero Life Sciences Ltd (TSE:SZLS)
TSX:SZLS
RESEARCH TOOLSreports
StageZero Life Sciences Ltd (SZLS) Stock Price & Analysis
57 Followers
SZLS Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.03 - C$0.08
Previous CloseC$0.03
Volume295.06K
Average Volume (3M)787.44K
Market Cap
C$4.08M
Enterprise ValueC$7.26M
Total Cash (Recent Filing)$5.54K
Total Debt (Recent Filing)$2.32M
Price to Earnings (P/E)―
Beta0.27
Next Earnings
Aug 13, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.16
Shares Outstanding123,553,050
10 Day Avg. Volume0
30 Day Avg. Volume787,437
Standard Deviation0.32
R-Squared0.00155
Alpha-0.00645
Financial Highlights & Ratios
Price to Book (P/B)-0.40
Price to Sales (P/S)6.32
Price to Cash Flow (P/CF)19.10
P/FCF Ratio12.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.56
Enterprise Value/Gross Profit-17.97
Enterprise Value/Ebitda-2.34
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
StageZero Life Sciences Ltd News
PremiumCompany Announcements
StageZero Faces Trading Halt Amid Financial Filing Delay
PremiumCompany Announcements
StageZero Reports Reduced Q1 Loss, Expands Partnerships
PremiumCompany Announcements
StageZero Faces Setback with Regulatory Compliance
PremiumCompany Announcements
StageZero Life Sciences Reports Filing DelayOptions Prices
Currently, No data available
---
Ownership Overview
23.83%
Insiders
0.00% Mutual Funds
0.01% Other Institutional Investors
76.16% Public Companies and
Individual Investors
SZLS FAQ
What was StageZero Life Sciences Ltd’s price range in the past 12 months?
StageZero Life Sciences Ltd lowest stock price was C$0.03 and its highest was C$0.07 in the past 12 months.
What is StageZero Life Sciences Ltd’s market cap?
Currently, no data Available
When is StageZero Life Sciences Ltd’s upcoming earnings report date?
StageZero Life Sciences Ltd’s upcoming earnings report date is Aug 13, 2024 which is in 39 days.
How were StageZero Life Sciences Ltd’s earnings last quarter?
StageZero Life Sciences Ltd released its earnings results on May 17, 2024. The company reported -C$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.004.
Is StageZero Life Sciences Ltd overvalued?
According to Wall Street analysts StageZero Life Sciences Ltd’s price is currently Overvalued.
Does StageZero Life Sciences Ltd pay dividends?
StageZero Life Sciences Ltd does not currently pay dividends.
What is StageZero Life Sciences Ltd’s EPS estimate?
StageZero Life Sciences Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does StageZero Life Sciences Ltd have?
StageZero Life Sciences Ltd has 123,553,050 shares outstanding.
What happened to StageZero Life Sciences Ltd’s price movement after its last earnings report?
StageZero Life Sciences Ltd reported an EPS of -C$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of StageZero Life Sciences Ltd?
Currently, no hedge funds are holding shares in TSE:SZLS
---
StageZero Life Sciences Ltd Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-44.52%
Trailing 12-Months
Company Description
StageZero Life Sciences Ltd
StageZero Life Sciences Ltd is a Canadian company which is focused on developing and commercializing proprietary molecular diagnostic tests for early detection of diseases and personalized health management, with a primary focus on cancer-related indications. It develops a proprietary platform technology, the Sentinel Principle, to identify novel biomarkers from whole blood. The lead product of the company is ColonSentry which is a blood test to determine the patient's current risk of having colorectal cancer.
---
Technical Analysis
---